Back to Newsroom
Back to Newsroom

CannaPharmRx, Inc. Completes Purchase of LTB Management, an E- Commerce and Financial Platform Company, and Launches New Corporate Website

Tuesday, 21 March 2023 08:30 AM

CannaPharmaRx

CALGARY, AB / ACCESSWIRE / March 21, 2023 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has finalized the purchase of LTB Management LLC (LTB), an e-commerce financial platform company utilized to support online sales for a variety of products.

With the closing, the company will not only begin to immediately book revenue, but also will be able to provide cutting-edge technology for online marketing, e-commerce, and advanced inventory management. In addition, the platform will also CannapharmaRx with international sales and marketing.

The company has recently unveiled an enhanced website that will be able to provide keen insight on company products, enable e-commerce marketing, and provide investors with important information about the company. Please visit https://cannapharmarx.com/ to view.

"We are confident about the current direction of the company. We have added a revenue stream and are close to completing our first harvest. We expect to produce and deliver at an annual run rate of nearly $30 million beginning in April," stated Chief Executive Officer, Dominic Colvin.

About CannapharmaRx, Inc.

CannapharmaRx is focused on the acquisition and development of state-of-the-art cannabis grow facilities in Canada. CPMD is in discussion with other companies regarding potential acquisitions. CannapharmaRx's business strategy is to become a leader in high quality and low-cost production of cannabis through the development, acquisition, and enhancement of existing facilities. CannapharmaRx is committed to operating high-quality facilities utilizing the latest technology in combined heat and power generation to ensure being a low-cost producer of cannabis.

Safe Harbor Statement

Cautionary Note Regarding Forward-Looking Information or Statements

This press release contains forward-looking information or statements. All statements that are or information which is not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations, or beliefs of future performance, are 'forward-looking information or statements.' Forward-looking information or statements can be identified by the use of words such as 'plans,' 'expects,' or 'does not expect,' 'is expected,' 'estimates,' 'intends,' 'anticipates,' or 'does not anticipate,' or 'believes,' or variations of such words and phrases or statements that certain actions, events or results 'may,' 'could,' 'would,' 'might' or 'will' be taken, occur or be achieved. With respect to forward-looking information and statements contained herein, Management of CannapharmaRx has made numerous assumptions, including, among other things, assumptions about general business and economic conditions. Such forward-looking statements are based on assumptions and involve known and unknown risks, uncertainties, and other factors that may cause actual results, events, or developments to be materially different from any future results, events, or developments expressed or implied by such forward-looking information or statements. Readers are cautioned not to place undue reliance on such forward-looking information or statements. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking information or statements. CannapharmaRx assumes no obligation to update any forward-looking information or statements, even if new information becomes available as a result of future events, new information, or for any other reason except as required by law.

Brokers and Analysts
Chesapeake Group
410-825-3930
[email protected]

SOURCE: CannaPharmaRx, Inc.

Topic:
Company Update
Back to newsroom
Back to Newsroom
Share by: